These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 2905101
1. [Therapy of peptic ulcer. H2 receptor blockers]. Domschke W. Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101 [No Abstract] [Full Text] [Related]
2. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W. Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]
3. [H2 receptor antagonists in the therapy of peptic ulcer disease]. Dammann HG, Dau B, Dreyer M, Müller P, Simon B. Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298 [Abstract] [Full Text] [Related]
4. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment]. Peitsch W. Zentralbl Chir; 1986 Aug; 111(23):1433-40. PubMed ID: 2881413 [Abstract] [Full Text] [Related]
5. [New therapy of peptic ulcer]. Harada T. Nihon Naika Gakkai Zasshi; 1995 Mar 10; 84(3):386-9. PubMed ID: 7751774 [No Abstract] [Full Text] [Related]
6. [Indications and successes of conservative therapy in gastroenterology: peptic ulcer]. Gugler R. Z Gastroenterol Verh; 1989 Jul 10; 24():82-4. PubMed ID: 2474995 [No Abstract] [Full Text] [Related]
7. [Long-term drug therapy of ulcer disease. Findings for deciding, indications, duration and surgical alternatives]. Peitsch W. Fortschr Med; 1986 Sep 25; 104(36):681-4. PubMed ID: 2876940 [No Abstract] [Full Text] [Related]
8. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer]. Glubochenko VG, Shcherbak VV. Vrach Delo; 1985 Feb 25; (2):13-5. PubMed ID: 2859701 [No Abstract] [Full Text] [Related]
9. [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Grigor'ev PIa, Isakov VA, Iakovenko EP. Ter Arkh; 1988 Feb 25; 60(8):118-26. PubMed ID: 2906485 [No Abstract] [Full Text] [Related]
10. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology. Gastroenterol Jpn; 1993 May 25; 28 Suppl 5():191-201. PubMed ID: 8103024 [No Abstract] [Full Text] [Related]
11. [Current aspects of course treatment and secondary prevention of peptic ulcer]. Ryss ES. Klin Med (Mosk); 1990 Apr 25; 68(4):134-42. PubMed ID: 1973467 [No Abstract] [Full Text] [Related]
12. [Antagonists of the histamine H2 receptors in the stomach]. Landa L. Gac Med Mex; 1981 Dec 25; 117(12):472-4. PubMed ID: 6123460 [No Abstract] [Full Text] [Related]
13. [A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer]. Di Mario F, Gottardello L, Burra P, Salvagnini M, Dalrì L, Leandro G, Contento F, Torri A, Naccarato R. G Clin Med; 1990 Apr 25; 71(4):259-62, 265-6. PubMed ID: 1973392 [Abstract] [Full Text] [Related]
16. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California. Am J Med; 1986 Oct 24; 81(4B):1-64. PubMed ID: 2877568 [No Abstract] [Full Text] [Related]
17. [Peptic ulcer--advances in drug therapy]. Gütz HJ. Z Arztl Fortbild (Jena); 1990 Oct 24; 84(16):811-3. PubMed ID: 1977243 [No Abstract] [Full Text] [Related]
18. [The interaction potential of H2 receptor antagonists. A short current review]. Klotz U, Kroemer HK. Fortschr Med; 1991 Sep 30; 109(28):574-6. PubMed ID: 1684557 [No Abstract] [Full Text] [Related]
19. [Peptic ulcer: current therapy]. Pieragnoli E. G Clin Med; 1987 Apr 30; 68(4):197-209. PubMed ID: 2886387 [No Abstract] [Full Text] [Related]
20. [The medical therapy of peptic ulcer. The state of the art]. Perroni GB, De Matteis G, Pellizzeri F, Cassone A, Malara F. Minerva Chir; 1992 Apr 15; 47(7):607-12. PubMed ID: 1350332 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]